Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
White Paper
Enemy at the Gate: Data Security Risks in Workers' Comp
The risk of a major data intrusion is a growing concern for every industry—and workers’ compensation is no ex
Workers' Comp
News Release
Case in Point Names Genex's Chris Burgess Platinum Award Winner
Catastrophic Case Manager Honored in Workers' Comp CategoryM
Risk & Insurance
In the News
Sub-par Compliance With Opioid Guidelines
Workers' Comp
News Release
Genex Case Managers' Survey Delivers Strategies to Avoid Claim Pitfalls
Communication issues cause of most problems in setting course of case, experts say April 28, 2015—Wayne, Pa.—Getting inj
Workers' Comp
White Paper
Using Big Data to Make Big Changes to Network Development
Check out Genex’s insight paper, “Using Big Data to Make Big Changes to Network Development,” written by Jim Harris, Genex’s vice president o
PC 360
Article
Property Casualty 360: The role of empathy in workers' comp
Most of us deal with sick and injured workers on a daily basis. At some point, daily tasks and deadlines take over and empathy takes a backseat.